Mohammad Javad Fattahi Selected Research

Mohammad Javad Fattahi Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 02/2007
9	Squamous Cell Carcinoma of Head and Neck 05/2018 - 05/2010
5	Rheumatoid Arthritis 06/2018 - 01/2012
5	Ankylosing Spondylitis 06/2018 - 11/2017
3	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2018
3	Inflammation (Inflammations) 04/2018 - 01/2013
3	Neoplasm Metastasis (Metastasis) 11/2014 - 04/2014
2	Carcinogenesis 01/2021 - 01/2018
2	Body Weight (Weight, Body) 04/2017 - 01/2015
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 03/2009 - 11/2008
2	Choriocarcinoma 03/2009 - 11/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Lymphatic Metastasis 05/2018
1	Pain (Aches) 04/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Leukocytosis (Pleocytosis) 10/2017
1	Multiple Sclerosis 04/2017
1	Arthritis (Polyarthritis) 01/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2015
1	Glomerulonephritis 01/2015
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2015
1	Carcinoma (Carcinomatosis) 04/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Oral Lichen Planus 12/2012
1	Heart Failure 12/2011
1	Malignant Pleural Effusion 12/2011
1	Pleural Effusion (Pleural Effusions) 12/2011
1	Lung Neoplasms (Lung Cancer) 12/2011
1	Ovarian Neoplasms (Ovarian Cancer) 11/2009
1	Breast Neoplasms (Breast Cancer) 02/2007

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2021 - 11/2009
9	mannuronic acidIBA 06/2018 - 01/2015
4	Therapeutic UsesIBA 12/2021 - 01/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2011
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 02/2018
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2018 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 12/2012
3	ImmunosorbentsIBA 01/2012 - 12/2011
3	EnzymesIBA 01/2012 - 12/2011
3	Interleukin-18 (Interleukin 18)IBA 03/2011 - 11/2008
2	Biological ProductsIBA 12/2021 - 03/2009
2	ProstaglandinsIBA 01/2014 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 12/2011
2	Codon (Codons)IBA 05/2010 - 02/2007
1	Pharmaceutical PreparationsIBA 06/2018
1	EndostatinsIBA 05/2018
1	Interleukin-27 (Interleukin 27)IBA 01/2018
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2018
1	NF-kappa B (NF-kB)IBA 11/2017
1	guluronic acidIBA 04/2017
1	Anti-Citrullinated Protein AntibodiesIBA 01/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2017
1	Rheumatoid FactorIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	anti-dsDNA autoantibodyIBA 01/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2014
1	Matrix Metalloproteinases (MMPs)IBA 06/2014
1	OsteopontinIBA 04/2014
1	Peptides (Polypeptides)IBA 01/2014
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 01/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2012
1	InterferonsIBA 12/2011
1	Interleukin-2 (IL2)IBA 12/2011
1	Interleukin-4 (Interleukin 4)IBA 12/2011
1	InterleukinsIBA 03/2011
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2009

Therapy/Procedure

2	Therapeutics 06/2018 - 10/2017
1	Oral Administration 04/2018
1	Oral Medicine 12/2012